Income Statement
LEXARIA BIOSCIENCE CORP.
LEXX
Performance Overview
Click any row in the table to add it to this chart
in millions USD
| Metric | Aug 31, 2025 2025 FY | Aug 31, 2024 2024 FY | Aug 31, 2023 2023 FY | Aug 31, 2022 2022 FY | Aug 31, 2021 2021 FY | Aug 31, 2020 2020 FY | Aug 31, 2019 2019 FY | Aug 31, 2018 2018 FY | Aug 31, 2017 2017 FY | Aug 31, 2016 2016 FY | Aug 31, 2015 2015 FY | Oct 31, 2013 2013 FY | Oct 31, 2012 2012 FY | Oct 31, 2011 2011 FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Revenue
|
0.71 | 0.46 | 0.23 | 0.26 | 0.72 | 0.38 | 0.22 | - | - | - | - | - | - | - |
|
Cost of Revenue
|
0.00 | 0.00 | 0.03 | 0.07 | 0.18 | 0.10 | 0.02 | 0.03 | - | - | - | 0.80 | 0.78 | 0.67 |
|
Gross Profit
|
0.70 | 0.46 | 0.19 | 0.18 | 0.55 | 0.29 | 0.20 | 0.41 | 0.03 | 0.00 | -0.02 | 0.30 | 0.57 | 0.47 |
|
Operating Expenses
|
12.58 | 6.21 | 6.73 | 7.57 | 6.23 | 4.37 | 4.36 | 7.02 | 1.96 | 1.27 | 1.97 | 0.65 | 0.83 | 1.00 |
|
Research & Development
|
8.24 | 2.36 | 3.67 | 1.84 | 1.26 | 0.39 | 0.56 | 0.49 | 0.05 | 0.01 | 0.15 | - | - | - |
|
Selling, General & Administrative
|
4.35 | 3.85 | 3.06 | 5.72 | 4.97 | 0.29 | 0.30 | 0.22 | 0.12 | 0.01 | 0.02 | 0.01 | 0.00 | 0.01 |
|
Other Operating Expenses
|
- | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
Operating Income
|
-11.88 | -5.75 | -6.53 | -7.38 | -5.69 | -4.08 | -4.16 | -6.61 | -1.93 | -1.28 | -1.98 | -0.34 | -0.25 | -0.54 |
|
Non-Operating Income
|
-0.03 | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
Interest Income
|
0.00 | 0.01 | 0.04 | - | - | - | - | - | - | - | - | - | - | - |
|
Interest Expense
|
- | - | - | - | - | - | - | - | 0.01 | 0.00 | 0.03 | 0.27 | 0.24 | 0.22 |
|
Other Non-Op Income / Expense
|
-0.03 | -0.06 | -0.18 | - | - | - | - | - | - | - | - | - | - | - |
|
Income Before Tax
|
-11.91 | -5.81 | -6.71 | -7.38 | -4.17 | -3.99 | -4.16 | -6.30 | - | - | - | - | - | - |
|
Income Tax Expense
|
- | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
Non-Controlling Interest
|
0.00 | -0.01 | 0.00 | -0.11 | 0.00 | -0.15 | - | -0.01 | -0.06 | -0.06 | -0.16 | - | - | - |
|
Net Income
|
0.00 | -5.80 | -6.66 | 0.00 | 0.00 | -4.08 | -4.16 | -6.61 | -1.93 | -1.28 | -1.98 | - | - | -0.54 |
Supplemental
Per share data, derived & other items — not part of the income statement
in millions USD unless noted
| Metric | Aug 31, 2025 2025 FY | Aug 31, 2024 2024 FY | Aug 31, 2023 2023 FY | Aug 31, 2022 2022 FY | Aug 31, 2021 2021 FY | Aug 31, 2020 2020 FY | Aug 31, 2019 2019 FY | Aug 31, 2018 2018 FY | Aug 31, 2017 2017 FY | Aug 31, 2016 2016 FY | Aug 31, 2015 2015 FY | Oct 31, 2013 2013 FY | Oct 31, 2012 2012 FY | Oct 31, 2011 2011 FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Depreciation & Amortization
|
- | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
EBITDA
|
-11.79 | -5.68 | -6.39 | -7.28 | -5.69 | -4.08 | -4.16 | -6.61 | -1.93 | -1.28 | -1.98 | -0.34 | -0.25 | -0.54 |
|
Earnings Per Share (Basic)
|
- | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
Diluted EPS
|
-0.66 | -0.47 | - | - | - | - | - | - | - | - | - | - | - | -0.04 |
|
Weighted Average Shares
|
- | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
Diluted Weighted Avg Shares
|
18.00 | 12.38 | - | - | - | - | - | - | - | - | - | - | - | 14.18 |
|
Comprehensive Income
|
-11.95 | -5.82 | - | - | - | - | - | -6.62 | - | - | -1.77 | -0.34 | -0.25 | -0.54 |